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Proteins that modify the structure of chromatin are known to be important
for various aspects of metazoan biology including development, disease
and possibly ageing. Yet functional details of why these proteins are
important, i.e. how their action influences a given biological process, are
lacking. While it is now possible to describe the biochemistry of how these
proteins remodel chromatin, their chromatin binding profiles in cell lines,
or gene expression changes upon loss of a given protein, in very few cases
has this easily translated into an understanding of how the function of that
protein actually influences a developmental process. Given that many chro-
matin modifying proteins will largely exert their influence through control
of gene expression, it is useful to consider developmental processes as
changes in the gene regulatory network (GRN), with each cell type exhibit-
ing a unique gene expression profile. In this essay we consider the impact
of two abundant and highly conserved chromatin modifying complexes,
namely the nucleosome remodelling and deacetylation (NuRD) complex
and the polycomb repressive complex 2 (PRC2), on the change in GRNs
associated with lineage commitment during early mammalian development.
We propose that while the NuRD complex limits the stability of cell states
and defines the developmental trajectory between two stable states, PRC2
activity is important for stabilizing a new GRN once established. Although
these two complexes display different biochemical activities, chromatin
binding profiles and mutant phenotypes, we propose a model to explain
how they cooperate to facilitate the transition through cell states that is
development.
Introduction
Each multicellular organism arises from a single cell.
During development, as cells divide and their numbers
multiply, different groups of cells take on different
roles. These different roles require cells to be able to
respond to different signals, and often they will need
to acquire drastically different morphologies to per-
form their roles adequately. Nearly all cells within an
organism carry the same genome, yet each cell type
has a distinct profile of gene expression to make it
most fit for purpose: each cell type will have a distinct
combination of genes which are on, off, primed or
oscillating. Despite all of this heterogeneity and poten-
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tial variability, animal development is normally very
predictable. This suggests that the ability to transit
between distinct gene expression profiles in a specific
order is highly robust.
One of the most powerful available models to study
differentiation between stably self-renewing cell types
is the embryonic stem (ES) cell. ES cells are cells
derived from the inner cell mass of a blastocyst-stage
embryo [1]. They can self-renew indefinitely in vitro,
and are prized because they promise the potential to
form any type of somatic tissue (i.e. they are pluripo-
tent). Indeed, the field of stem cell biology holds
immense potential to positively impact human health
through regenerative medicine [2–4], where stem cells
could, in theory, be used to create any tissue type of
need for the medical and/or pharmaceutical industry.
However, in order to achieve this very broad aim, we
must be able to both understand and control human
development. In order to control development, we
must be able to understand and control gene expres-
sion.
From observation, we know that an individual cell
is able to react appropriately to signals from its sur-
roundings whilst also being able to act upon internal
programmes. Thus, it is clear that cells are capable of
integrating multiple forms of information and are able
to compute decisions based on this. We know that
ordinary, wild-type ES cells are capable of self-renewal
and differentiation. Furthermore, they have the capa-
bility to differentiate into more than one cell type,
such that in certain culture conditions they can appar-
ently choose between different fates, resulting in heter-
ogeneous cultures. That is, cells which are exposed to
seemingly identical conditions can exhibit different
behaviours. So the question here is: how are these cells
choosing one fate over another? Or, more precisely, by
what mechanisms are the cells integrating and inter-
preting signals from their surroundings, and how can
these interpretations result in different behaviours
between cells in a clonal cell population?
One of the key mechanisms in allowing cells to
respond to instructions and to modulate gene tran-
scription is the chromatin modifying machinery. Com-
plexes such as the nucleosome remodelling and
deacetylation (NuRD) complex and the polycomb
repressive complexes (PRC1/PRC2) are capable of
remodelling and/or modifying chromatin, and all play
important roles in cell differentiation. Previous reviews
have focused on the physical changes to chromatin
which accompany differentiation. In this review we
consider what roles chromatin modifying complexes
play in ES cell differentiation, but with a focus on the
potential effects of these complexes on the dynamics of
the transcription factor gene regulatory network
(GRN) rather than on the physical chromatin itself.
Mouse embryonic stem cells
Mouse ES cells have a relatively open chromatin struc-
ture which becomes denser upon differentiation. Dur-
ing differentiation, there is a wide-scale repression of
ES-cell-state-related genes. This is achieved by a com-
bination of factors, but the two we shall consider most
closely here are histone modifications and nucleosome
remodelling.
As well as allowing genome packaging, nucleosomes
are employed in the regulation of transcription [5–7].
Nucleosome-level regulation is broadly concerned with
controlling access of polymerases and transcription
factors, increasing or decreasing the likelihood of tran-
scription. This can be achieved by changing the loca-
tion of nucleosomes with a nucleosome remodeller
(e.g. by Chd4 in the NuRD complex or Brg1 in esBAF
[5,8,9]) or by chemically modifying the histones at
their N-terminal tails or globular domains (e.g.
H3K27me3 by PRC2 [10,11]). All chromatin modifica-
tions like this are reversible and dynamic, although
some can be maintained over many generations, giving
rise to a type of cellular memory [12].
In standard culture conditions, and even in the rela-
tively homogeneous, chemically defined two-inhibitor
(2i) culture condition [13,14], mouseES cells are not
completely homogeneous [15–18]. If we have a popula-
tion of ES cells which spawn from a single cell, which
self-renew, and which are morphologically indistin-
guishable from one another, we will nevertheless find
subpopulations with discretely different gene expres-
sion profiles. Furthermore, these different patterns of
expression can bias the cell towards self-renewal or dif-
ferentiation, but at the same time the patterns can be
dynamic and transient, creating temporal windows-of-
opportunity for choosing a particular fate [19,20]. This
already gives us some insight to the dynamics of the
system.
The heterogeneity of gene expression seen in ES cells
is often attributed to a combination of cellular noise,
oscillating circuits [21] and various switches embedded
in the GRN [19,22]. The concept of cellular noise
intends to capture all of the factors which lead to ran-
dom variability in cells – something of a formal
acknowledgement of the messiness of biology [23–25].
Within this, sources of noise are often classed as
intrinsic or extrinsic, although the boundary between
the classes can be blurred [26–28].
In practice, factors which introduce intrinsic noise
introduce variation to intracellular events which
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should be identically regulated (such as the random
diffusion of macromolecules causing localized changes
in the equilibria of biomolecular reactions [29]).
Extrinsic noise refers to the variation of identically
regulated events across a population of cells. Examples
of this include differences in cell-cycle stage, differ-
ences in organelle distribution, or any environmental
stimuli. This physical messiness gives a plausible driver
for ES cell heterogeneity.
One of the most interesting aspects of ES cell heter-
ogeneity is the fact that cells appear to be able to
express many genes at broadly discrete levels (we very
often find two steady states – to simplify, ON or OFF)
and that, when measured across multiple generations,
clonal cell populations can shift dynamically between
the levels. The expression of the transcription factor
NANOG is probably the most intensively studied
example of this behaviour [16,17,30–32]. Multiple
models have been proposed to explain how the
dynamic switching of NANOG expression occurs, but
as yet none fully captures the effect. Alongside
NANOG, several other ‘pluripotency-related’ tran-
scription factors are also heterogeneously expressed in
mouseES cells, notably KLF4, KLF5 [33,34], REX1
(Zfp42 [35,36]), TBX3 [34], ESRRB [1] and STELLA
(Dppa3) [37].
Cell types as high-dimensional
attractors in gene expression state
space
In a multicellular organism there can be hundreds of
different identifiable cell types, and all of them will
contain the same set of digitally encoded instructions:
the genome. But what is a cell type? As a researcher, it
is possible to class a cell based on its morphology, by
the expression of certain genes, by the context in
which it is found in, and by its behaviour in response
to its environment. However, this does not address cell
identity and the relationship between developmental
lineages at a fundamental level [22,38].
Development is often described as if it is determinis-
tic: zygote becomes morula becomes blastocyst etc.
But, as alluded to above, there is a degree of stochas-
ticity in development which is probably attributable to
a combination of the often small numbers of each
chemical species and biological noise [25,28,39]. This
apparent paradox between developmental predictabil-
ity and stochasticity can be resolved by considering the
behaviour of a cell as a dynamical system [38,40,41].
One way of doing this based purely on gene expression
is to categorize a cell’s type by measuring its gene
expression profile and assigning a cell state, S. The cell
state is jointly defined by the expression of all genes in
the genome x1, x2, . . ., xN, and so each state S = [x1,
x2, . . ., xN] represents a coordinate in state space
(Fig. 1) [38]. Using this dynamical systems conception,
different cell types thus occupy different regions in
state space, and changes in expression are accompa-
nied by the movement of S along one of a set of tra-
jectories. GRNs include many nodes (genes) which
directly influence the expression of other nodes,
namely the transcription factors [42–44]. By nature this
restricts the scope of potential trajectories.
A
B
Fig. 1. ES cell differentiation landscape. Model in which the GRN
is indicated as a 3D surface, with all possible gene expression
combinations existing as discrete coordinates in 2D state space.
Some coordinates (meaning combinations of expression patterns)
are more likely or more stable than others, and are called
‘attractors’. For example, in (A) positions 1 and 2 indicate stable or
highly probable attractor states, whereas position 3 indicates a
very unstable/unlikely position. Position 1 in (A) represents self-
renewing cells in 2i/LIF conditions and position 2 represents ES
cells in serum/LIF conditions. Upon loss of self-renewal signals (B),
the resulting GRN no longer favours attractors 1 or 2, which
become very unstable. In contrast attractors 4, 5 and 6 have
become more stable and can attract cells traversing the landscape.
These would represent entry points into different differentiation
pathways. During normal development cells can only move from
left to right in this model. Moving from right to left would only
occur during experimental reprogramming. NuRD activity is
predicted to limit the depth of the attractors and/or define the
trajectories, displayed here as troughs, between attractors. PRC2
function is proposed to be required to stabilize/maintain the
attractors.
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We can consider that, due to gene expression noise,
the expression of any gene xi will fluctuate, and so the
cell state S will move around in state space. If all
genes were independent of each other, then S could be
found at any coordinate. However, in biological sys-
tems, genes are not regulated totally independently of
one another. In fact, there is a very high degree of
inter-regulation, meaning that certain gene expression
states are possible or even likely, whilst others are
close to impossible to achieve. Thus, there are areas of
state space which are more and less likely to be
explored (Fig. 1). Of the more likely areas of state
space, there are points where all regulatory interac-
tions are satisfied. These are stable points called attrac-
tors [38,40]. Once in an attractor, small perturbations
in gene expression will not cause xi to fluctuate too
much, and so S is likely to fall back to the centre of
the attractor. Large perturbations allow S to transit
out of the basin of attraction, possibly towards
another attractor. In this model, each different cell
type would be an attractor in an ever evolving land-
scape of attractors [22].
The connections between nodes within the GRN can
have a profound effect on the potential phenotypes of a
cell and can influence the manner in which the cell can
change phenotypes and differentiate. The attractor
states encoded within the GRN topology are perhaps
the most fundamental defining feature of cell type [24].
Next, we consider how chromatin modifying complexes
can act upon the GRN, how they aid the transitions
between cell types and how they allow the stabilization
and establishment of differentiated cell types.
Chromatin modifying complexes and
the dynamics of the GRN
Here, we ask what role or roles a chromatin modifying
complex occupies during the differentiation of cells,
specifically ES cells. For the most part, the roles of
chromatin modifying complexes have been described
based on their physical effect on the chromatin. We
can reduce differentiation and development to two
central requirements: (a) the cell state must be able to
transition from one stable state to another, with the
differentiated state having some new ability (or set of
abilities) required for further survival and/or growth;
(b) the further transitions [i.e. further differentiation or
the reverse transition (de-differentiation)] should nor-
mally be difficult to achieve, unless the correct envi-
ronmental cues are present. We will refer to these two
requirements as ‘transition’ and ‘establishment’.
We can think of differentiation as occurring when
there is a bifurcation in phase space, i.e. something
changes which causes a qualitative change in the
behaviour of the system. Intuitively, chromatin remo-
dellers could facilitate these bifurcation events in two
broad ways. First, chromatin modifying complexes
generally associate with a huge number of genetic con-
trol elements (promoters, enhancers etc.), and so their
effect is felt at all points across the GRN. However,
they also tend to have a high degree of specificity, and
it is often observed (and assumed) that this specificity
is mediated by complex transcription factor interac-
tions. If this is so, chromatin modifiers should have a
role in mediating the connections between nodes in the
GRN. In doing this, the trajectories that a cell can
take to move through phase space would be deter-
mined to some degree by chromatin modifying com-
plexes. This could be seen as a form of intrinsic
control over the transition stage of differentiation.
Second, genes within heterochromatic regions can-
not be expressed. A gene in this condition has been
effectively removed from the GRN, and the GRN has
effectively been shrunk. In this establishment step, we
would now expect the nature of the attractor states to
change and for the reverse transition to be energeti-
cally unfavourable.
Considering cell states and developmental transition
in this way allows us to predict phenotypes arising
from various scenarios: if the transition is difficult, the
cells will appear resistant to differentiation; if the
establishment is difficult, the cells will be able to differ-
entiate but appear to fail to commit to a new state; if
too much of the required GRN is removed, then the
cell may die or adopt a qualitatively wrong cell state;
if too little of the GRN is turned off, then the cell
may adopt a qualitatively wrong state.
We shall now explore how the mutant phenotypes
of cells lacking two well-studied chromatin modifying
complexes (NuRD and PRC2) would fit these descrip-
tions and what possible further insights these would
offer (for detailed reviews of the molecular biology of
these complexes, see [5,9,10]).
The NuRD complex
The NuRD complex is a multi-protein complex which
is abundant in mammalian cells [45–47]. Its biochemi-
cally defined roles are to remodel chromatin and to de-
acetylate histones. Indeed, based on this histone
deacetylase activity, it has commonly been referred to
as a transcriptional co-repressor complex [45,47]. How-
ever, more recent evidence suggests that the presence
of the complex at a gene locus is just as likely to be
associated with active transcription as repressed tran-
scription [48–51].
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Mouse ES cells lacking the NuRD complex are, to
an extent, stuck in the ‘ES’ cell state. That is, they
self-renew but struggle to differentiate. Similarly,
in vivo, NuRD-null epiblast cells fail to develop, result-
ing in failure to form the embryo proper. Whereas
wild-type ES cells cultured in standard self-renewal
conditions differentiate within two to three generations
after withdrawal of leukaemia inhibitory factor (LIF),
NuRD-deficient ES cells will continue to self-renew
indefinitely [52]. Additionally, under standard ES cell
culture conditions, wild-type-ES cell cultures consist of
a heterogeneous mix of self-renewing and spontane-
ously differentiating cells, whereas NuRD-mutant ES
cells do not show any signs of spontaneous differentia-
tion. The NuRD complex also appears to have a high-
level role in creating ES cell heterogeneity; one of the
features of the NuRD-mutant ES cell phenotype is a
loss of certain subpopulations as defined by transcrip-
tion factor protein levels [34].
Where does NuRD function fit within our model of
differentiation as a transition between stable states
within the GRN? The NuRD complex (like all chroma-
tin remodelling complexes) can be considered to be a
general purpose tool which is employed by transcrip-
tion factors at various gene loci to modify chromatin
structure [53,54], acting globally to define the overall
shape of the GRN. In this scenario, loss of the NuRD
complex (or of any other chromatin remodelling com-
plex) would alter the topology of the network. In the
case of mouse pluripotent cells, absence of NuRD cre-
ates a more stable, more uniform ‘self-renewing’ state,
where the probability that a cell can leave this state is
much reduced. Thus NuRD can normally be considered
to function to limit the stability of this pluripotent cell
state, either by controlling the ‘depth’ of the ES cell
state or by facilitating the transition away from the plu-
ripotent cell state upon loss of self-renewal signals.
Could NuRD also be important for cells to main-
tain the identity of secondary cell states, i.e. those cells
into which pluripotent cells differentiate? We find this
to be less likely. One reason for this is that the
NuRD-dependent differentiation seen in ES cells is
context-dependent: under normal differentiation condi-
tions, i.e. those to which pluripotent cells are exposed
in an implantation-stage embryo, NuRD function is
required for differentiation. In other contexts, such as
upon treatment with differentiation-inducing drugs,
injection under an adult kidney capsule or induction
towards a trophectoderm fate, NuRD-deficient cells
readily differentiate [52,55–57]. Further, while NuRD
function is required for ES cells to form neural pro-
genitor cells in culture, loss of NuRD in established
neural progenitor cultures does not impair mainte-
nance of these cells [52,58]. Therefore we favour a sce-
nario in which control of gene expression by the
NuRD complex is not important for maintaining the
identity of somatic cell types. These examples also
indicate that NuRD function is not absolutely required
to define differentiation trajectories as, if given suffi-
ciently strong extracellular signals, cells are able to find
their way along a differentiation path. This is entirely
consistent with NuRD defining the topology of the
GRN, making the differentiation paths accessible to a
pluripotent cell under normal, physiological condi-
tions. However, if these cells are exposed to signals
normally only seen much later in development (e.g.
retinoic acid, or the extracellular milieu surrounding a
kidney capsule), then this is sufficient to override any
NuRD dependence upon differentiation.
Studies in somatic stem cell types support the notion
that NuRD function defines the trajectories between
cell states, but not that it influences the stability of a
stem cell state. The founding NuRD component pro-
tein CHD4 (Mi-2b) has been shown to be important
for developmental transitions in embryonic skin, i.e.
for the normal progression of one epidermal progeni-
tor cell to differentiate into another [59]. Similarly,
deletion of Chd4 in haematopoietic stem cells prevents
neither self-renewal nor exiting the stem cell state;
however, these stem cells produce an inappropriate
mix of progenitor cell types [60]. Loss of the NuRD
scaffold protein MBD3 during neural development
results in a failure of neural progenitors to produce a
normal complement of downstream cell types (Knock
et al., in revision). Whilst it certainly is the case that
the NuRD complex has tissue-specific behaviours and
conformations [61–64], these studies are consistent
with NuRD functioning to define differentiation trajec-
tories in a number of different mammalian cell types.
PRC2 and bivalent chromatin
PRC2 plays an essential role during embryonic devel-
opment in mice and, indeed, in most other character-
ized metazoans (see for a recent review [10]). In mice,
lack of the core PRC2 components EED, EZH2 or
SUZ12 results in embryonic failure during the eighth
or ninth day of development [65–67], placing its essen-
tial function slightly later than that of NuRD, which is
required during the fifth day of development [55].
PRC2 maintains genes in a repressed state via the di-
and tri-methylation of histone H3 at lysine 27 [68]. It
has been noted that this mark, which is associated
with transcriptional silencing, can coexist on promot-
ers with a mark of actively transcribed genes,
H3K4Me3, in a so-called ‘bivalent’ chromatin state
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[69–71]. Although this bivalent chromatin status was
initially identified in mouseES cells and therefore
thought to be a hallmark of stem cells, it was subse-
quently shown to also exist in differentiated cell types
and is thus not a stem-cell-specific phenomenon
[72,73].
The bivalent domain was first postulated to be a
mark of promoters for which transcription was poised:
not fully active (hence the H3K27Me3) and not fully
repressed (due to the presence of H3K4Me3), but
could quickly be turned either on or off depending
upon which signals were received by the cell [71]. In
this model of H3K27Me3 function, PRC2 could be
seen to act to ensure cells remained responsive to dif-
ferentiation signals, rather like the function described
for NuRD above. Yet unlike NuRD, PRC2 compo-
nents are not required for cells to exit the pluripotent
state or for the onset of gastrulation during mouse
embryogenesis [65–67]. Indeed, careful analyses of
early epiblast cells in gastrulating embryos found that
EED was not necessary for cells crossing the primitive
streak to adopt their normal mesodermal fates, but
defects were found in the function and behaviour of
these resulting PRC2-mutant mesodermal cells [65,74].
These phenotypes do not appear consistent with a
model in which PRC2, and by extension a bivalent
chromatin state, is important for lineage fate choice.
Despite its general acceptance and popularity, a
number of strands of evidence are beginning to cast
doubt on the ‘bivalency-as-developmental poising’
model. ES cells lacking PRC2 components are able to
self-renew without large-scale activation of differentia-
tion-associated genes, demonstrating that PRC2 func-
tion (and, by extension, H3K27Me3) is not strictly
required to prevent activation of this class of genes
[75–78]. Culturing mouseES cells in conditions known
to minimize transcriptional and functional heterogene-
ity, so-called 2i media [13,14], results in a reduction in
global H3K27Me3 but no increase in precocious
expression of lineage-specific transcription [79]. More
compelling evidence came from deletion of the histone
methyltransferase required for deposition of
H3K4Me3 marks specifically at bivalent promoters,
MLL2, which did not result in failure of developmen-
tal gene activation upon induction of ES cell differenti-
ation [80]. This study provides strong genetic evidence
that bivalency per se is not required for developmental
priming of gene expression. A similar result was found
when Mll2 was knocked down in ES cells [81]. The
importance of PRC2 function in early embryonic
development is incontrovertible; however, the evidence
does not support a role in specifying early cell fate
decisions.
So how could the demonstrated function of PRC2 in
mammalian development fit within our model of line-
age commitment as a cell transiting between attractor
states? PRC2 recruitment in ES cells is reliant on the
transcriptional status of its target genes rather than by
the action of any particular transcription factors [82]. It
is associated with specific loci at different points in
development, but this may be as a secondary effect to
the genes being turned off by other means. As such,
unlike NuRD, its primary function would be to main-
tain inactive genes in a silent, unresponsive state, and it
would have less of an influence on the strength of con-
nections within the network. This would serve to effec-
tively remove nodes from the GRN and thus change
the dynamics of the system. In other words, its primary
role would be to maintain the stability (or ensure
proper identity) of a specific cell state.
A function for PRC2 in stabilizing cell states is sup-
ported by the initial suggestion that lack of PRC2
components was incompatible with ES cell self-renewal
[83]. It has subsequently become apparent that these
ES cells actually are able to self-renew but show preco-
cious differentiation and activation of some differentia-
tion markers, i.e. cell state instability. Notably if these
cells are cultured in 2i conditions they become consid-
erably more stable [82]. That PRC2 functions in cell
state stability is further supported by the behaviour of
PRC2-mutant ES cells upon withdrawal of self-renewal
signals. ES cells lacking the PRC2 component SUZ12
initially adopt gene expression profiles similar to their
wild-type counterparts early in differentiation, consis-
tent with them being able to both exit the self-renew-
ing state and begin to transit to a new state (Fig. 1B).
However, after several days they revert to an ES-cell-
like stable state [82]. This observation can be inter-
preted to indicate that without PRC2-mediated main-
tenance of transcriptional silencing the GRN is unable
to properly stabilize in a non-ES-cell-like state.
PRC2 and NuRD combine to define
cell fates
Defining NuRD and PRC2 function in terms of how
they influence the topology of the differentiation land-
scape, it is possible to make predictions about how the
two would work together during differentiation. Spe-
cifically, NuRD activity would facilitate the exit of a
cell from a given attractor state, either by destabilizing
that attractor state or by defining differentiation tra-
jectories, whereas PRC2 would ensure that once the
cell arrives at a new state it would remain there.
One example of just such a partnership between
NuRD and PRC2 is in the silencing of Hox loci in
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Drosophila melanogaster. During development, pro-
teins encoded by the gap genes, such as Hunchback
(Hb), maintain the appropriate spatial expression pat-
terns of Hox gene expression by repressing their tran-
scription outside of normal expression domains [84–86].
The transcriptional repressor Hb recruits the NuRD
component protein dMi-2 to establish transcriptional
silencing at Hox loci [87], thus establishing the posi-
tional identity of a cell. Although this expression
pattern is maintained throughout development, expres-
sion of Hb is quickly lost after this establishment step
and repression at these silenced Hox loci is maintained
by PRC2. In the absence of PRC2 function the correct
positional identity of cells is lost as appropriate Hox
gene expression patterns are not maintained. Thus, in
this case, NuRD and PRC2 act in sequential but sepa-
rate steps of gene repression and cell fate determina-
tion: NuRD is used to establish the expression state,
whereas PRC2 is used to maintain it.
A further example is provided in Caenorhabditis ele-
gans, where orthologues of two NuRD components
(Let418/Chd4 and Hda1/Hdac1) function to facilitate
transition out of the germline state after fertilization
[88]. That is, their activity is important to allow the
genome to properly respond to differentiation signals
which will instruct the fertilized egg to develop into an
embryo, whereas maintenance of the specific cellular
states is carried out, at least in part, by orthologues of
the polycomb group proteins [88]. Remarkably, a simi-
lar function for NuRD component proteins had previ-
ously been described in Arabidopsis thaliana, in that a
Chd4 orthologue was shown to be important to pre-
vent embryonic characteristics in somatic tissues [89–
91].
How might such an order of events work mechanis-
tically? One potential mechanism is provided by the
seemingly complementary enzymatic activities of the
two complexes. Transcriptional repression by NuRD is
associated with loss of acetylation of H3K27, a mark
of active transcription. This deacetylated H3K27 resi-
due then becomes a substrate for the histone methyl-
transferase activity of PRC2, which facilitates mono-,
di- and tri-methylation of H3K27 [92,93]. Therefore
NuRD and PRC2 have the potential to act in tandem
to change an active histone mark to a repressive mark.
This mechanism was shown to occur at a subset of
NuRD and PRC2 target genes in ES cells [94] and
may well occur in somatic cells as well [95].
Genome-wide chromatin binding data in self-renew-
ing mouseES cells show that NuRD components and
PRC2 components colocalize at a relatively small sub-
set of either complex’s array of bound genomic loca-
tions [94]. This could mean that the two complexes do
not tend to be present at the same loci at the same
time, due to the sequential nature of their respective
activities, or it could indicate that the examples
described above represent a relatively infrequent occur-
rence of NuRD–PRC2 functional interaction. In the
latter case we would predict that PRC2 and NuRD
combine with other chromatin modifying protein com-
plexes to carry out the functions described above, with
the identities of these other complexes depending upon
the cell type and lineage decision in question. Further,
NuRD components are more likely to be found at
actively transcribed genes than at silent genes [48–51].
This indicates that, most of the time, mammalian
NuRD does not silence transcription as in the example
of dMi2 and HOX genes in Drosophila, but rather
modulates levels of active transcription [34,48]. There-
fore it makes intuitive sense that only occasionally
would this modulation require enforcement of tran-
scriptional silencing by PRC2.
Concluding remarks – and a get-out
clause
Here we propose a hypothesis to explain how two
chromatin modifying complexes influence the GRN
and thereby function during mammalian development.
This is based upon an existing model of ‘development
as changes in the GRN’, which in turn is designed to
help us better understand the biology we observe. We
are aware that no model can fully describe every
nuance of mammalian development nor take into con-
sideration the >4500 citations in PubMed referring to
NuRD and/or polycomb. The hypothesis we propose
is designed to form a platform upon which to base fur-
ther experiments and, like most good hypotheses, to
be knocked down by clever experiments and replaced
by another hypothesis based upon a more accurate
model. It should also be pointed out that given the
scale of genome-wide data on PRC2 and NuRD bind-
ing events and associated gene expression data, it will
always be possible to find examples where these mod-
els and hypotheses do not hold true. Nevertheless we
argue that these ideas do describe much of the pheno-
typic data present in the literature and are therefore
useful.
The packaging of DNA into chromatin was a hugely
important innovation in the evolution of eukaryotic
organisms, and the regulation of chromatin has been
shown time and again to be of crucial importance to
cell survival and decision making. What has been less
well explored is the role of chromatin repressive com-
plexes in the regulation of the dynamics of the GRN.
Admittedly, the dynamics of cell decision making is
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something of an open question, with suggestions and
demonstrations of switching behaviours and oscilla-
tions at the local level, to critical-like self-organization
at the level of the whole network [96,97]. What we
have hoped to demonstrate is that, by stepping back
from the molecular details, we may be able to under-
stand the higher-level functions of these molecular
machines and thereby better understand how the enzy-
matic activities contained within these complexes are
harnessed to facilitate metazoan development.
There are a number of strands of thought that lead
from this point. Much of the ability of a cell to com-
pute decisions is presumed to be based on the dynam-
ics of the system [98]. In a GRN, chromatin repressive
complexes influence the expression of a large number
of genes, placing them at the heart of cellular decision
making. Therefore it is hoped that by concentrating
on the higher-level effects of chromatin regulation in
phase space we may gain entirely new insights into the
use and evolution of chromatin-mediated regulation of
cell fate decisions.
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